tirzepatide eli lily Blood sugar drug also leads to substantial weight loss in diabetes patients, Lilly says Lilly's tirzepatide cuts diabetes risk,

The British Heart Foundation (BHF) has appointed research leader and NHS consultant physician Bryan Williams as its first chief scientific and medical officer

"We identified a greater chance of successful weight loss in a group with a higher proportion of females and those with no medical conditions linked to obesity." The good doctor also pointed out that, regardless of when a GLP-1 weight loss plateau occurred, most participants maintained "clinically meaningful weight loss over 3 years, regardless of age, duration of obesity, and BMI." You might also be happy to know that losing 15% of your body weight is the benchmark for reaping the most benefits from GLP-1 medications

Wegovy is the licensed semaglutide product specifically for weight management

If youre considering Mounjaro, working with a provider like Gard Wellness Solutions can help ensure your treatment is managed with both your mental and physical well-being in mind